Microfluidics: A new tool for modeling cancer-immune interactions.


In recognition of the enormous potential of immunotherapies against cancer, research into the interactions between tumor and immune cells has accelerated, leading to the recent FDA approval of several drugs that reduce cancer progression. Numerous cellular and molecular interactions have been identified by which immune cells can intervene in the metastatic… (More)


Cite this paper

@article{BoussommierCalleja2016MicrofluidicsAN, title={Microfluidics: A new tool for modeling cancer-immune interactions.}, author={Alexandra Boussommier-Calleja and Ran Li and M. B. Chen and Siew Cheng Wong and Roger D. Kamm}, journal={Trends in cancer}, year={2016}, volume={2 1}, pages={6-19} }